Literature DB >> 2552823

Angiotensin receptors and angiotensin I-converting enzyme in rat intestine.

K A Duggan1, F A Mendelsohn, N R Levens.   

Abstract

The purpose of this study was to map the distribution of angiotensin II (ANG II) receptors and ANG I-converting enzyme (ACE) in rat intestine. ANG II binding sites were visualized by in vitro autoradiography using iodinated [Sar1, Ile8]ANG II. The distribution of ACE was mapped using an iodinated derivative of lisinopril. Male Sprague-Dawley rats were killed and the interior of the whole intestine washed with ice-cold saline. Segments of duodenum, jejunum, ileum, and colon were quickly frozen in a mixture of isopentane and dry ice. Twenty-micron frozen sections were thaw-mounted onto gelatin-coated slides, incubated with either ligand, and exposed to X-ray film. After exposure and subsequent development, the films were quantitated by computerized densitometry. ANG II receptors were most dense in the colon, followed by the ileum, duodenum, and jejunum. Within each segment of intestine, specific ANG II binding sites were localized exclusively to the muscularis. In contrast, ACE was present in both the mucosa and the muscularis. The colocalization of ANG II receptors and ACE may suggest a role for locally generated ANG II in the control of intestinal function. The luminal orientation of ACE in the mucosa of the small intestine may suggest that at this site ACE serves primarily to hydrolyze dietary peptides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552823     DOI: 10.1152/ajpgi.1989.257.4.G504

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Inflammation alters angiotensin converting enzymes (ACE and ACE-2) balance in rat heart.

Authors:  Sherif Hanafy; Mahtab Tavasoli; Fakhreddin Jamali
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

2.  Action of ANG II and ANP on colon epithelial cells.

Authors:  Raif Musa-Aziz; Margarida Mello-Aires
Journal:  Pflugers Arch       Date:  2005-07-07       Impact factor: 3.657

3.  ACE inhibition by enalaprilate stimulates duodenal mucosal alkaline secretion via a bradykinin pathway in the rat.

Authors:  L Chen; M Holm; L Fändriks; A Pettersson; B Johansson
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

4.  Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice.

Authors:  John J Byrnes; Stefan Gross; Courtney Ellard; Kelly Connolly; Stephen Donahue; Dominic Picarella
Journal:  Inflamm Res       Date:  2009-06-11       Impact factor: 4.575

5.  Expression of the mouse ren-2 gene in the small intestine is regulated by food intake.

Authors:  Y Zhao; J Peters; D Ganten; M Bader
Journal:  Pflugers Arch       Date:  1993-08       Impact factor: 3.657

6.  Bradykinin regulates human colonic ion transport in vitro.

Authors:  A W Baird; M M Skelly; D P O'Donoghue; K E Barrett; S J Keely
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

7.  Angiotensin converting enzyme in renal ontogeny: hypothesis for multiple roles.

Authors:  F F Jung; B Bouyounes; R Barrio; S S Tang; D Diamant; J R Ingelfinger
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

8.  Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model.

Authors:  Ryo Sueyoshi; Kathleen M Woods Ignatoski; Stephanie Daignault; Manabu Okawada; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2013-08-15       Impact factor: 3.199

9.  Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition.

Authors:  Ariel U Spencer; Hua Yang; Emir Q Haxhija; Barbara E Wildhaber; Joel K Greenson; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

10.  The bradykinin BK2 receptor mediates angiotensin II receptor type 2 stimulated rat duodenal mucosal alkaline secretion.

Authors:  Sara Ewert; Berndt Johansson; Mathias Holm; Herbert F Helander; Lars Fandriks
Journal:  BMC Physiol       Date:  2003-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.